Literature DB >> 19188768

Current status of renal radiofrequency ablation.

William A Carraway1, Jay D Raman, Jeffrey A Cadeddu.   

Abstract

PURPOSE OF REVIEW: To provide an overview of the current literature addressing the role of radiofrequency ablation (RFA) for the management of renal cortical tumors. RECENT
FINDINGS: As the renal RFA experience continues to mature, longer-term data addressing the oncologic efficacy of this ablative modality are now available. Furthermore, the impact of RFA on secondary clinical endpoints, such as renal function outcomes, has now been addressed in several series.
SUMMARY: With the stage migration toward diagnosis of smaller renal masses, energy ablative techniques are being increasingly utilized as primary surgical modalities. Here, we review the role of RFA for the management of such masses and comment on technical considerations for this particular ablative technique. In addition, we provide a summary of contemporary longer-term oncologic outcomes and review the impact of RFA on renal function. As more renal masses are diagnosed in the elderly or comorbid patients, it is likely that ablative approaches will assume an increasingly central role in management strategies. In this regard, continued studies are necessary, particularly in regards to oncologic outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19188768     DOI: 10.1097/MOU.0b013e328323f5c2

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  9 in total

Review 1.  Image-guided percutaneous ablation of renal tumors: outcomes, technique, and application in urologic practice.

Authors:  Adam C Mues; Jaime Landman
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

Review 2.  Kidney function outcomes following thermal ablation of small renal masses.

Authors:  Jay D Raman; Syed M Jafri; David Qi
Journal:  World J Nephrol       Date:  2016-05-06

3.  Doppler signals observed during high temperature thermal ablation are the result of boiling.

Authors:  Volodymyr M Nahirnyak; Eduardo G Moros; Petr Novák; V Suzanne Klimberg; Gal Shafirstein
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

4.  Current and future technology for minimally invasive ablation of renal cell carcinoma.

Authors:  Branden G Duffey; J Kyle Anderson
Journal:  Indian J Urol       Date:  2010-07

5.  Radiofrequency Ablation-Assisted Zero-Ischemia Robotic Laparoscopic Partial Nephrectomy: Oncologic and Functional Outcomes in 49 Patients.

Authors:  Kalen Rimar; Aziz Khambati; Barry B McGuire; David A Rebuck; Kent T Perry; Robert B Nadler
Journal:  Adv Urol       Date:  2016-12-01

6.  Association among the R.E.N.A.L. nephrometry score and clinical outcomes in patients with small renal masses treated with percutaneous contrast enhanced ultrasound radiofrequency ablation.

Authors:  Cristian Konstantinidis; Enrique Trilla; Xavier Serres; Carolina Montealegre; David Lorente; Rafael Castellón; Juan Morote
Journal:  Cent European J Urol       Date:  2019-06-04

7.  Current status of ablative therapies for renal tumors.

Authors:  Adam C Mues; Jaime Landman
Journal:  Indian J Urol       Date:  2009 Oct-Dec

8.  Contrast-enhanced ultrasonography follow-up after radiofrequency ablation in normal rabbit kidney.

Authors:  Rong Wu; Fan-Hua Xu; Ming-Hua Yao; Juan Xie; Bing Hu
Journal:  Arch Med Sci       Date:  2013-08-29       Impact factor: 3.318

9.  Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma.

Authors:  Chad J Cooper; Mohamed Teleb; Alok Dwivedi; Gabriela Rangel; Luis A Sanchez; Shaked Laks; Nassim Akle; Zeina Nahleh
Journal:  Rare Tumors       Date:  2015-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.